That would make sense. I had thought there was an increase in MRR that may not have flowed through in time for the quarterly but wanted to be conservative. If rollout was done early this quarter then $310 ARR gives $77.5k quarterly, which is in the ballpark of my $60k conservative estimate. Plus any additional increment from the 20 new RACs
- Forums
- ASX - By Stock
- Ann: PainChek Granted US Patent for Pain Assessment Invention
That would make sense. I had thought there was an increase in...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PCK (ASX) to my watchlist
|
|||||
Last
3.4¢ |
Change
0.003(9.68%) |
Mkt cap ! $55.61M |
Open | High | Low | Value | Volume |
3.4¢ | 3.4¢ | 3.4¢ | $10.93K | 321.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 90865 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 398789 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 90865 | 0.034 |
1 | 193831 | 0.031 |
11 | 3057000 | 0.030 |
5 | 9813448 | 0.029 |
3 | 475000 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.038 | 398789 | 2 |
0.039 | 200000 | 1 |
0.040 | 50000 | 1 |
0.042 | 334333 | 3 |
0.043 | 250000 | 1 |
Last trade - 15.32pm 11/09/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |